House Energy and Commerce Committee leaders Aug. 30 sent a letter to the Medicare Payment Advisory Commission asking it to conduct additional research on hospital consolidation and the financial impact it has on Medicare patients and the program. Among other areas, the committee asks MedPAC to examine recent trends in hospital consolidation and the effects on hospitals and patients’ costs; how the integration between physicians and hospitals has affected Medicare payments for physician services; and questions related to the use of the 340B drug savings program. A 2017 study prepared for the AHA by Charles River Associates found that hospital mergers result in efficiencies, savings, innovation and quality improvements essential to transforming health care delivery, all of which benefits patients. The committee asks MedPAC to respond to this request within 30 days.
 

Related News Articles

Headline
The Medicare Payment Advisory Commission March 15 released its March report to Congress, which includes its recent recommendations for hospital and other…
Blog
The Medicare Payment Advisory Commission (MedPAC) today released its annual March Report advising Congress on the Medicare fee-for-service (FFS) payment…
Headline
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues…
Headline
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by…
Headline
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains…
Headline
AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B…